Balancing hemorrhagic and thrombotic complications in a patient with a very late paclitaxel-eluting stent thrombosis: A clinical case report

Journal of Cardiovascular Medicine

Volumn 12, Issue 5, 2011, Pages 366-369

  Esposito, Giovanni ^a   Cassese, Salvatore ^a   Gargiulo, Giuseppe ^a   Sannino, Anna ^a   Schiattarella, Gabriele Giacomo ^a   Piscione, Federico ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

hemorrhagic complications; paclitaxel eluting stent; very late stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FOLIC ACID; HEPARIN; OMEPRAZOLE; PACLITAXEL;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; CASE REPORT; CONTINUOUS INFUSION; DRUG ELUTING STENT; FEMALE; HUMAN; PACLITAXEL ELUTING STENT; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; RIGHT CORONARY ARTERY; RISK FACTOR; STENT THROMBOSIS; VERY LATE STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; DRUG ADMINISTRATION SCHEDULE; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; HEMORRHAGE; HUMANS; PACLITAXEL; PLATELET AGGREGATION INHIBITORS; THROMBOSIS; TIME FACTORS;

EID: 79955482530     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328337583a     Document Type: Article

References (10)

1. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel angioplasty prognosis study group. Circulation 1990; 82:1193-1202.
2. Jamshidi P, Toggweiler S, Erne P. In-stent restenosis and thrombosis 41 months after drug-eluting stent implantation. Int J Cardiol 2008; 130:e111-e113.
3. Nilsen DW, Melberg T, Larsen AI, Barvik S, Bonarjee V. Late complications following the deployment of drug eluting stents. Int J Cardiol 2006; 109:398-401.
4. Grines CL, Bonow RO, Casey DE Jr, Gardner TJ, Lockhart PB, Moliterno DJ, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115:813-818. (Pubitemid 46294748)
5. Sardella G, Mancone M, Bucciarelli-Ducci C, Agati L, Scardala R, Carbone I, et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial. J Am Coll Cardiol 2009; 53:309-315.
6. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130. (Pubitemid 40617065)
7. Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008; 29:2909-2945.
8. Rinaldi MJ, Kirtane AJ, Piana RN, Caputo RP, Gordon PC, Lopez JJ, et al. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events. Am Heart J 2008; 155:654-660.
9. Park DW, Yun SC, Lee JY, Kim WJ, Kang SJ, Lee SW, et al. C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation. Circulation 2009; 120:1987-1995.
10. Germing A, von Dryander S, Machraoui A, Bojara W, Lawo T, Grewe P, et al. Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting. Heart Vessels 2000; 15:263-267. (Pubitemid 33114964)